Maze Therapeutics, Inc. (MAZE): SCHEDULE 13G/A filed Nov 13, 2025

Form type

SCHEDULE 13G/A

Filing date

Nov 13, 2025

Accession number

0000902664-25-004912

Filer

Maze Therapeutics, Inc. (CIK 1842295)